Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)
TipRanksApr 22 02:50 ET
Arcutis Biotherapeutics Analyst Ratings
BenzingaApr 12 06:43 ET
Analysts Are Bullish on These Healthcare Stocks: GoodRx Holdings (GDRX), Arcutis Biotherapeutics (ARQT)
TipRanksApr 12 06:40 ET
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT)
TipRanksApr 10 02:30 ET
Buy Rating on Arcutis Biotherapeutics Bolstered by Projected Q1 Sales Beat and 2024 Upside Potential
TipRanksApr 10 02:21 ET
Analysts Offer Insights on Healthcare Companies: Marinus (MRNS), Arcutis Biotherapeutics (ARQT) and Axsome Therapeutics (AXSM)
TipRanksMar 27 03:20 ET
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Fulcrum Therapeutics (FULC) and AC Immune SA (ACIU)
TipRanksMar 19 01:50 ET
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Adaptimmune Therapeutics (ADAP) and Arcutis Biotherapeutics (ARQT)
TipRanksMar 13 02:30 ET
Arcutis Biotherapeutics Analyst Ratings
BenzingaFeb 28 07:37 ET
Arcutis Biotherapeutics (ARQT) Gets a Hold From JonesTrading
TipRanksFeb 27 18:25 ET
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Arcutis Biotherapeutics (ARQT)
TipRanksFeb 27 16:40 ET
Buy Rating Affirmed for Arcutis Biotherapeutics as Zoryve Sales Surge and Market Position Strengthens
TipRanksFeb 27 12:35 ET
Arcutis Biotherapeutics Analyst Ratings
BenzingaFeb 23 10:25 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Walgreens Boots Alliance (WBA) and Twist Bioscience (TWST)
TipRanksFeb 7 10:20 ET
Maintaining a Hold: Arcutis Biotherapeutics' Mixed Q4 Outlook and Zoryve Market Potential
TipRanksJan 29 17:15 ET
Buy Rating for Arcutis Biotherapeutics Amidst Strong Zoryve Foam Launch and Market Penetration Potential
TipRanksJan 24 01:40 ET
Goldman Sachs Reaffirms Their Hold Rating on Arcutis Biotherapeutics (ARQT)
TipRanksJan 22 18:45 ET
Mizuho Upgrades Arcutis to Buy, Cites Zoryve Sales
Seeking AlphaJan 3 10:25 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcutis Biotherapeutics (ARQT) and Axsome Therapeutics (AXSM)
TipRanksJan 2 23:50 ET
Mizuho Upgrades Arcutis Biotherapeutics to Buy, Raises Price Target to $8
BenzingaJan 2 16:19 ET
No Data
No Data